These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas. Bremer K J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340 [TBL] [Abstract][Full Text] [Related]
4. Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease. Gibbs WN; Lofters WS; Campbell M; Hanchard B; LaGrenade L; Clark J; Cranston B; Saxinger C; Gallo R; Blattner WA Princess Takamatsu Symp; 1984; 15():77-90. PubMed ID: 6100652 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study. Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A; Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608 [TBL] [Abstract][Full Text] [Related]
7. [Biermer's anemia with chronic lymphoid leukemia and hemolysis with autoantibodies]. Zittoun R; Zittoun J; Bousser J Sem Hop; 1975 Jan; 51(4):233-5. PubMed ID: 167442 [TBL] [Abstract][Full Text] [Related]
8. Autoimmune haemolytic anaemia: pattern of presentation and management outcome in a Nigerian population: a ten-year experience. Salawu L; Durosinmi MA Afr J Med Med Sci; 2002 Jun; 31(2):97-100. PubMed ID: 12518900 [TBL] [Abstract][Full Text] [Related]
9. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases]. Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412 [TBL] [Abstract][Full Text] [Related]
10. [Long-term observation of patients with autoimmune hemolytic anemia]. Kopeć I; Słomkowski M; Przybyszewska M; Szczepanik K; Maj S Acta Haematol Pol; 1991; 22(1):58-68. PubMed ID: 1823969 [TBL] [Abstract][Full Text] [Related]
11. [Idiopathic cold agglutinin disease. Clinical aspects, therapy and course in 6 patients]. Budmiger H; Rhyner K; Siegenthaler-Zuber G; Bollinger A Schweiz Med Wochenschr; 1988 Jan; 118(2):52-7. PubMed ID: 3344409 [TBL] [Abstract][Full Text] [Related]
13. Gamma heavy chain "disease": heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature. Fermand JP; Brouet JC; Danon F; Seligmann M Medicine (Baltimore); 1989 Nov; 68(6):321-35. PubMed ID: 2509855 [TBL] [Abstract][Full Text] [Related]
14. Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia: a case series and review of the literature. Hill J; Walsh RM; McHam S; Brody F; Kalaycio M Am J Hematol; 2004 Mar; 75(3):134-8. PubMed ID: 14978692 [TBL] [Abstract][Full Text] [Related]
15. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related]
16. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study. Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661 [TBL] [Abstract][Full Text] [Related]
17. Severe autoimmune hemolytic anemia in eight patients treated with fludarabine. Gonzalez H; Leblond V; Azar N; Sutton L; Gabarre J; Binet JL; Vernant JP; Dighiero G Hematol Cell Ther; 1998 Jun; 40(3):113-8. PubMed ID: 9698219 [TBL] [Abstract][Full Text] [Related]
18. Incidence and prognostic significance of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukemia (CLL). De Rossi G; Granati L; Girelli G; Gandolfo G; Arista MC; Martelli M; Conti L; Marini R; La Tagliata R; Leone R Nouv Rev Fr Hematol (1978); 1988; 30(5-6):403-6. PubMed ID: 3222151 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol]. Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405 [TBL] [Abstract][Full Text] [Related]
20. [Information value of isoelectric focusing of serum proteins in non-Hodgkin's lymphomas]. Koĭcheva N; Naĭdenov K; Usheva R Vutr Boles; 1988; 27(2):71-4. PubMed ID: 3137729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]